Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4825)
All Articles published online
|
Jun 14, 2012 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Valenti L, Maggioni P, Piperno A, Rametta R, Pelucchi S, Mariani R, Dongiovanni P, Fracanzani AL, Fargion S. |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i22/2813.htm |
| Number | Citing Articles |
| 1 |
Stefano Romeo, Arun Sanyal, Luca Valenti. Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease. Cell Metabolism 2020; 31(1): 35 doi: 10.1016/j.cmet.2019.12.002
|
| 2 |
Paola Dongiovanni, Stefano Romeo, Luca Valenti. Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/460190
|
| 3 |
T. Herta, J. Fischer, T. Berg. Genetik metabolischer und viraler Lebererkrankungen. Der Gastroenterologe 2017; 12(1): 16 doi: 10.1007/s11377-016-0128-y
|
| 4 |
Yelena Z. Ginzburg, Karin E. Finberg. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics. 2021; : 445 doi: 10.1016/B978-0-12-812535-9.00012-1
|
| 5 |
Jessica Seeßle, Hongying Gan-Schreier, Marietta Kirchner, Wolfgang Stremmel, Walee Chamulitrat, Uta Merle. Plasma Lipidome, PNPLA3 polymorphism and hepatic steatosis in hereditary hemochromatosis. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01282-3
|
| 6 |
Liana Gheorghe, Speranta Iacob. Essentials of Non-Alcoholic Fatty Liver Disease. 2023; : 133 doi: 10.1007/978-3-031-33548-8_12
|
| 7 |
Salvatore Petta, Luca Valenti, Elisabetta Bugianesi, Giovanni Targher, Stefano Bellentani, Ferruccio Bonino, Ele Ferrannini, Carmela Loguercio, Amedeo Lonardo, Fabio Marra, Marcello Mancini, Luca Miele, Valerio Nobili, Gianluca Svegliati Baroni, Federico Alessandro, Stefano Ballestri, Maurizia Rossana Brunetto, Barbara Coco, Antonio Grieco, Silvia Fargion, Loreta Kondili, Fabio Nascimbeni, Anna Prinster, Dante Romagnoli, Stefano Taddei, Ester Vanni, Stefano Vella. A “systems medicine” approach to the study of non-alcoholic fatty liver disease. Digestive and Liver Disease 2016; 48(3): 333 doi: 10.1016/j.dld.2015.10.027
|
| 8 |
Peter J Meffert. Effects of the PNPLA3–SNP rs738409 on Serum Transaminase levels are modified by body mass index and alcohol consumption. Biometrics & Biostatistics International Journal 2018; 7(4) doi: 10.15406/bbij.2018.07.00227
|
| 9 |
James C. Barton, Christine E. McLaren, Wen-pin Chen, Grant A. Ramm, Gregory J. Anderson, Lawrie W. Powell, V. Nathan Subramaniam, Paul C. Adams, Pradyumna D. Phatak, Lyle C. Gurrin, John D. Phillips, Charles J. Parker, Mary J. Emond, Gordon D. McLaren. Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes. Annals of Hepatology 2018; 17(5): 871 doi: 10.5604/01.3001.0012.3169
|
| 10 |
Yan Zhao, Wenli Zhao, Jingchao Ma, Maeda Toshiyoshi, Ye Zhao. Patatin-like phospholipase domain-containing 3 gene (PNPLA3) polymorphic (rs738409) single nucleotide polymorphisms and susceptibility to nonalcoholic fatty liver disease: A meta-analysis of twenty studies. Medicine 2023; 102(10): e33110 doi: 10.1097/MD.0000000000033110
|
| 11 |
Maria Antonella Burza, Antonio Molinaro, Maria Luisa Attilia, Claudia Rotondo, Fabio Attilia, Mauro Ceccanti, Flaminia Ferri, Federica Maldarelli, Angela Maffongelli, Adriano De Santis, Adolfo Francesco Attili, Stefano Romeo, Stefano Ginanni Corradini. PNPLA3 I148M (rs738409) genetic variant and age at onset of at‐risk alcohol consumption are independent risk factors for alcoholic cirrhosis. Liver International 2014; 34(4): 514 doi: 10.1111/liv.12310
|
| 12 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 2961 doi: 10.1007/978-3-319-26956-6_165
|
| 13 |
Luca Valenti, Serena Pelusi, Luisa Ronzoni. Comprehensive Guide to Hepatitis Advances. 2023; : 443 doi: 10.1016/B978-0-323-98368-6.00013-6
|
| 14 |
Nirupama Trehanpati, Dinesh Rawat, Hamed Hemati. Genome Analysis and Human Health. 2017; : 43 doi: 10.1007/978-981-10-4298-0_3
|
| 15 |
Monika Rau, Katharina Baur, Andreas Geier. Host Genetic Variants in the Pathogenesis of Hepatitis C. Viruses 2012; 4(12): 3281 doi: 10.3390/v4123281
|
| 16 |
George G. Schweitzer, Brian N. Finck. Targeting Hepatic Glycerolipid Synthesis and Turnover to Treat Fatty Liver Disease. Advances in Hepatology 2014; 2014: 1 doi: 10.1155/2014/498369
|
| 17 |
Sara Pelucchi, Stefania Galimberti, Federico Greni, Raffaela Rametta, Raffaella Mariani, Irene Pelloni, Domenico Girelli, Fabiana Busti, Giulia Ravasi, Maria Grazia Valsecchi, Luca Valenti, Alberto Piperno. Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE‐related hemochromatosis. Journal of Gastroenterology and Hepatology 2016; 31(7): 1342 doi: 10.1111/jgh.13315
|
| 18 |
Olivier Loréal, Thibault Cavey, François Robin, Moussa Kenawi, Pascal Guggenbuhl, Pierre Brissot. Iron as a Therapeutic Target in HFE-Related Hemochromatosis: Usual and Novel Aspects. Pharmaceuticals 2018; 11(4): 131 doi: 10.3390/ph11040131
|
| 19 |
Darrell H. G. Crawford, Grant A. Ramm, Kim R. Bridle, Amanda J. Nicoll, Martin B. Delatycki, John K. Olynyk. Clinical practice guidelines on hemochromatosis: Asian Pacific Association for the Study of the Liver. Hepatology International 2023; 17(3): 522 doi: 10.1007/s12072-023-10510-3
|
| 20 |
Cristina Maglio, Carlo Pirazzi, Arturo Pujia, Luca Valenti, Stefano Romeo. The PNPLA3 I148M variant and chronic liver disease: When a genetic mutation meets nutrients. Food Research International 2014; 63: 239 doi: 10.1016/j.foodres.2014.01.055
|
| 21 |
Benedetta Donati, Benedetta Maria Motta, Piero Pingitore, Marica Meroni, Alessandro Pietrelli, Anna Alisi, Salvatore Petta, Chao Xing, Paola Dongiovanni, Benedetta del Menico, Raffaela Rametta, Rosellina Margherita Mancina, Sara Badiali, Anna Ludovica Fracanzani, Antonio Craxì, Silvia Fargion, Valerio Nobili, Stefano Romeo, Luca Valenti. The rs2294918 E434K variant modulates patatin‐like phospholipase domain‐containing 3 expression and liver damage. Hepatology 2016; 63(3): 787 doi: 10.1002/hep.28370
|
| 22 |
Samantha G. Tilson, Carola M. Morell, An‐Sofie Lenaerts, Seung Bum Park, Zongyi Hu, Benjamin Jenkins, Albert Koulman, T. Jake Liang, Ludovic Vallier. Modeling PNPLA3‐Associated NAFLD Using Human‐Induced Pluripotent Stem Cells. Hepatology 2021; 74(6): 2998 doi: 10.1002/hep.32063
|
| 23 |
Kalliopi Azariadis, Nikolaos K. Gatselis, Aggeliki Lyberopoulou, Pinelopi Arvaniti, Kalliopi Zachou, Stella Gabeta, George N. Dalekos. PNPLA3 I148 M genetic variant in autoimmune hepatitis characterises advanced disease at diagnosis and reduced survival free of cirrhotic events and liver-related mortality. Journal of Translational Autoimmunity 2024; 9: 100243 doi: 10.1016/j.jtauto.2024.100243
|
| 24 |
Amit G Singal, Hema Manjunath, Adam C Yopp, Muhammad S Beg, Jorge A Marrero, Purva Gopal, Akbar K Waljee. The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysis. American Journal of Gastroenterology 2014; 109(3): 325 doi: 10.1038/ajg.2013.476
|
| 25 |
Silvia Sookoian, Carlos J. Pirola, Luca Valenti, Nicholas O. Davidson. Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology. Hepatology 2020; 72(1): 330 doi: 10.1002/hep.31229
|
| 26 |
Tyler J Severson, Siddesh Besur, Herbert L Bonkovsky. Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review. World Journal of Gastroenterology 2016; 22(29): 6742-6756 doi: 10.3748/wjg.v22.i29.6742
|
| 27 |
Eric Trépo, Luca Valenti. Update on NAFLD genetics: From new variants to the clinic. Journal of Hepatology 2020; 72(6): 1196 doi: 10.1016/j.jhep.2020.02.020
|
| 28 |
Albert Friedrich Stättermayer, Stefan Traussnigg, Hans-Peter Dienes, Elmar Aigner, Rudolf Stauber, Karoline Lackner, Harald Hofer, Judith Stift, Friedrich Wrba, Andreas Stadlmayr, Christian Datz, Michael Strasser, Andreas Maieron, Michael Trauner, Peter Ferenci. Hepatic steatosis in Wilson disease – Role of copper and PNPLA3 mutations. Journal of Hepatology 2015; 63(1): 156 doi: 10.1016/j.jhep.2015.01.034
|
| 29 |
Luca Valenti, Paola Dongiovanni, Stefano Ginanni Corradini, Maria Antonella Burza, Stefano Romeo. PNPLA3 I148M variant and hepatocellular carcinoma: A common genetic variant for a rare disease. Digestive and Liver Disease 2013; 45(8): 619 doi: 10.1016/j.dld.2012.12.006
|
| 30 |
Antonello Pietrangelo. Zakim and Boyer's Hepatology. 2018; : 941 doi: 10.1016/B978-0-323-37591-7.00060-4
|
| 31 |
Paola Dongiovanni, Luca Valenti. Genetics of nonalcoholic fatty liver disease. Metabolism 2016; 65(8): 1026 doi: 10.1016/j.metabol.2015.08.018
|
| 32 |
Jian-Hua Shen, Yi-Ling Li, Dan Li, Ning-Ning Wang, Lei Jing, Yu-Hong Huang. The rs738409 (I148M) variant of the PNPLA3 gene and cirrhosis: a meta-analysis. Journal of Lipid Research 2015; 56(1): 167 doi: 10.1194/jlr.M048777
|
| 33 |
Elena Corradini, Elena Buzzetti, Antonello Pietrangelo. Genetic iron overload disorders. Molecular Aspects of Medicine 2020; 75: 100896 doi: 10.1016/j.mam.2020.100896
|
| 34 |
Pierre Brissot, Thibault Cavey, Martine Ropert, François Gaboriau, Olivier Loréal. Hemochromatosis: a model of metal-related human toxicosis. Environmental Science and Pollution Research 2018; 25(3): 2007 doi: 10.1007/s11356-016-7576-2
|
| 35 |
Paola Dongiovanni, Stefano Romeo, Luca Valenti. Hepatocellular carcinoma in nonalcoholic fatty liver: Role of environmental and genetic factors. World Journal of Gastroenterology 2014; 20(36): 12945-12955 doi: 10.3748/wjg.v20.i36.12945
|
| 36 |
Stephan Buch, Aneesh Sharma, Eleanor Ryan, Christian Datz, William J. H. Griffiths, Michael Way, Thomas W. M. Buckley, John D. Ryan, Stephen Stewart, Callum Wright, Paola Dongiovanni, Anna Fracanzani, Jochen Zwerina, Uta Merle, Karl Heinz Weiss, Elmar Aigner, Elisabeth Krones, Christian Dejaco, Janett Fischer, Thomas Berg, Luca Valenti, Heinz Zoller, Andrew McQuillin, Jochen Hampe, Felix Stickel, Marsha Y. Morgan. Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in hereditary haemochromatosis. Alimentary Pharmacology & Therapeutics 2021; 53(7): 830 doi: 10.1111/apt.16252
|
| 37 |
Antonello Pietrangelo. Iron and the liver. Liver International 2016; 36(S1): 116 doi: 10.1111/liv.13020
|
| 38 |
Eric Trépo, Stefano Romeo, Jessica Zucman-Rossi, Pierre Nahon. PNPLA3 gene in liver diseases. Journal of Hepatology 2016; 65(2): 399 doi: 10.1016/j.jhep.2016.03.011
|
| 39 |
O. V. Smirnova, O. L. Moskalenko, E. V. Kasparov, I. E. Kasparova. Genetic predictors and pathophysiological features of non-alcoholic fat liver disease. Meditsinskiy sovet = Medical Council 2021; (15): 78 doi: 10.21518/2079-701X-2021-15-78-87
|
| 40 |
Pavel Trunečka, Irena Míková, Dana Dlouhá, Jaroslav A. Hubáček, Eva Honsová, Libor Kolesár, Věra Lánská, Soňa Fraňková, Jan Šperl, Milan Jirsa, Rudolf Poledne. Donor PNPLA3 rs738409 genotype is a risk factor for graft steatosis. A post-transplant biopsy-based study. Digestive and Liver Disease 2018; 50(5): 490 doi: 10.1016/j.dld.2017.12.030
|
| 41 |
Antonello Pietrangelo. Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin. Gastroenterology 2015; 149(5): 1240 doi: 10.1053/j.gastro.2015.06.045
|
| 42 |
Luca Valenti, Anna Ludovica Fracanzani, Raffaela Rametta, Mirella Fraquelli, Giulia Soverini, Serena Pelusi, Paola Dongiovanni, Dario Conte, Silvia Fargion. Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis. Journal of Hepatology 2012; 57(6): 1319 doi: 10.1016/j.jhep.2012.07.041
|
| 43 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_165-1
|
| 44 |
John K. Olynyk, Richard Grainger, Helen Currie, Louise E. Ramm, Grant A. Ramm. The ancestral haplotype markers HLA -A3 and B7 do not influence the likelihood of advanced hepatic fibrosis or cirrhosis in HFE hemochromatosis. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-35028-4
|